Showing results (281-290 of 1,061) with videos related to
Sort By:
Pageof 107
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
B-vitamins are potentially a cost-effective population health strategy to tackle dementia: Too good to be true?Apostolos Tsiachristas, A David SmithAlzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
First-in-human, double-blind, placebo-controlled, single-dose escalation study of aducanumab (BIIB037) in mild-to-moderate Alzheimer's diseaseJames Ferrero, Leslie Williams, Heather Stella, et al.Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Insufficient evidence for vitamin E in Alzheimer's diseaseDirk M HermannAlzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Design of the NL-ENIGMA study: Exploring the effect of Souvenaid on cerebral glucose metabolism in early Alzheimer's diseaseNienke M E Scheltens, Ingrid S Kuyper, Ronald Boellaard, et al.Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
SAR110894, a potent histamine H3-receptor antagonist, displays disease-modifying activity in a transgenic mouse model of tauopathyPhilippe Delay-Goyet, Véronique Blanchard, Nathalie Schussler, et al.Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Zfra restores memory deficits in Alzheimer's disease triple-transgenic mice by blocking aggregation of TRAPPC6AΔ, SH3GLB2, tau, and amyloid β, and inflammatory NF-κB activationMing-Hui Lee, Yao-Hsiang Shih, Sing-Ru Lin, et al.Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Associations between social relationship measures, serum brain-derived neurotrophic factor, and risk of stroke and dementiaJoel Salinas, Alexa Beiser, Jayandra J Himali, et al.Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Differential medial temporal lobe morphometric predictors of item- and relational-encoded memories in healthy individuals and in individuals with mild cognitive impairment and Alzheimer's diseaseJesus J Gomar, J Daniel Ragland, Aziz M Uluğ, et al.Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
UB-311, a novel UBITh® amyloid β peptide vaccine for mild Alzheimer's diseaseChang Yi Wang, Pei-Ning Wang, Ming-Jang Chiu, et al.Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Patients' and caregivers' views on conversations and shared decision making in diagnostic testing for Alzheimer's disease: The ABIDE projectMarleen Kunneman, Ruth Pel-Littel, Femke H Bouwman, et al.Pageof 107